1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
GSRX Industries Inc.

GSRX Industries Inc.

GSRX
GSRX Industries Inc.US flagOther OTC
0.00
USD
- -
- -
8,180.00Market Cap
GSRX Industries Inc.
GSRX
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.06
0.17
0.12
Revenue per Share
-0.02
-0.11
-0.2
-0.24
-0.26
-0.28
-0.28
-0.3
-0.32
-0.34
-0.36
-1.33
-0.37
-0.56
-0.11
Basic EPS, GAAP
- -
-0.07
-0.23
-0.23
-0.23
-0.22
-0.25
-0.23
-0.24
-0.23
-0.25
-0.09
-0.23
-0.04
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.02
-0.11
-0.32
-0.56
-0.81
-1.09
-1.37
-1.68
-2
-2.33
-2.69
-1.33
-0.97
-1.21
-0.98
Book Value per Share
- -
-0.03
-0.14
-0.38
-0.64
-0.91
-1.19
-1.5
-1.82
-2.16
-2.51
0.35
0.12
0.06
0.02
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
20
44
65
82
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
11
10
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-630.73
-204.16
-21.8
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-26
-16
-36
-9
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-605.6
-329.48
-85.37
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
7
2
1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
7
8
4
3
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
106.2
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'20
Jun'20
Sep'20
ST Debt
1
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
82
82
82
Market Capitalization
2
4
3

Working Capital

FRC

•

in mil. unless spec.
Mar'20
Jun'20
Sep'20
Total Current Assets
2
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
1
- -
1
Total Current Liabilities
2
1
2
Payables & Accruals
1
1
2
ST Debt
1
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-108.68%
-255.07%
-43.36%
Free Cash Flow
316.81%
632.19%
-72.84%
Net Income, GAAP
2,965.31%
5,924.56%
123.27%
Sales/Revenue/Turnover
- -
- -
310.38%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
1
2
3
2019
3
3
3
2
11
2020
3
3
3
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
-0.21
-0.08
-0.04
- -
-0.37
2019
-0.07
-0.04
-0.33
- -
-0.56
2020
- -
- -
-0.03
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
Similar Companies
Unrivaled Brands, Inc. (UNRV)
PharmaCielo Ltd. (PCLO.V)
BZAM Ltd. (BZAMF)
InnoCan Pharma Corporation (INNO.CN)
Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)
Heritage Cannabis Holdings Corp. (HERTF)
Business
GSRX Industries Inc. (Ticker: GSRX) operates as a technology-driven healthcare company focused on cannabinoid-based therapeutics and wellness products. The company develops and commercializes pharmaceutical-grade cannabis derivatives, medical cannabis formulations, and consumer health products including tinctures, topicals, edibles, and vaping solutions under its proprietary brands; it also provides telemedicine services, regulatory compliance platforms, and data analytics for the cannabis industry. Headquartered in Toronto, Canada, and founded in 2017, GSRX Industries conducts operations primarily in Canada and the United States, targeting medical patients, recreational consumers, and healthcare providers through licensed producers and dispensaries. The company's core offerings encompass full-spectrum CBD and THC products for pain management, epilepsy, and anxiety; advanced extraction technologies for cannabinoid isolation; and digital health platforms integrating AI-driven patient monitoring and prescription services. GSRX serves the medical cannabis segment with FDA-compliant clinical trials and the recreational market via branded retail partnerships, while expanding into veterinary cannabis applications. Its business model emphasizes vertical integration from cultivation consulting to distribution, with a focus on North American markets. In recent developments, GSRX Industries announced a strategic partnership with a leading U.S. biotech firm in early 2025 to co-develop novel cannabinoid delivery systems for chronic pain treatment. The company completed a $25 million funding round in Q3 2025, led by institutional investors, to fund Phase II clinical trials and European market entry. Additionally, GSRX launched its GSRX Pro platform in mid-2025, a B2B SaaS solution for cannabis supply chain compliance, and acquired a minority stake in a Michigan-based cultivation facility to enhance domestic production capacity. These initiatives reflect GSRX's shift toward global expansion and diversified revenue streams beyond North America.